- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Florida Society of Clinical Oncology Recognize FCS President For Advocacy Achievements and Leadership
Michael Diaz, MD, president & managing physician of Florida Cancer Specialists & Research Institute, was announced as the recipient of the Florida Society of Clinical Oncology Dorothy Green Phillips Legacy Award 2022.
Fort Myers, Florida — Michael Diaz, MD, president & managing physician of Florida Cancer Specialists & Research Institute (FCS), was announced as the recipient of the Florida Society of Clinical Oncology (FLASCO) Dorothy Green Phillips Legacy Award 2022 at FLASCO’s Annual Gala held on May 6 in Orlando, Florida.
Named in honor of Dorothy Green Phillips, who retired in 2019 after serving as FLASCO Executive Director, the award is presented annually to a FLASCO member whose contributions leave a lasting legacy. In announcing her selection, Phillips cited Diaz’ tireless efforts to be an example for his peers and an advocate for his patients.
"Dr Diaz is an exceptional physician and recognized nationally as a leader in community oncology. His contributions through the years have had enormous positive impacts that will benefit patients, providers, and communities for years to come,” said Nathan H. Walcker, MBA, chief executive officer, FCS.
Politics vs Science: The Future of US Public Health
February 4th 2025On this episode of Managed Care Cast, we speak with Perry N. Halkitis, PhD, MS, MPH, dean of the Rutgers School of Public Health, on the public health implications of the US withdrawal from the World Health Organization and the role of public health leaders in advocating for science and health.
Listen
“Expanding Access Isn’t Just About Fairness—It’s About Building Better Treatments for Everyone”
February 16th 2025Regina Barragan-Carrillo, MD, a postdoctoral fellow at City of Hope Comprehensive Cancer Center, discussed findings that show 76% of renal cell carcinoma trials take place in wealthy countries, amid news that clinical trial access for the world's poor may become even more challenging.
Read More
